mibefradil has been researched along with atrial natriuretic factor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, JS; Cho, KW; Cui, X; Kim, SH; Kim, SZ; Lee, HS; Park, YK; Seul, KH; Wen, JF | 1 |
| Chen, B; Dai, Y; Deng, JL; Guo, SD; Li, PL; Shan, MY; Xu, ZH; Zhang, KB; Zhao, LG | 1 |
2 other study(ies) available for mibefradil and atrial natriuretic factor
| Article | Year |
|---|---|
Distinct roles for L- and T-type Ca(2+) channels in regulation of atrial ANP release.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Atrial Natriuretic Factor; Bodily Secretions; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Diltiazem; Extracellular Space; Heart Atria; In Vitro Techniques; Mibefradil; Myocardial Contraction; Myocardium; Rabbits; Stroke Volume | 2000 |
Mibefradil Alleviates High-Glucose-induced Cardiac Hypertrophy by Inhibiting PI3K/Akt/mTOR-mediated Autophagy.
Topics: Animals; Atrial Natriuretic Factor; Autophagy; Calcium Channel Blockers; Cardiomegaly; Cell Line; Cell Size; Glucose; Mibefradil; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |